HIV, Tuberculosis, Hepatitis B, and Hepatitis C: Drugs, Diagnostics, Vaccines, and Microbicides in Development by Lei Chou, Mark Harrington, Bob Huff, Richard Jefferys, Tracy Swan, Javid Syed, and Claire Wingfield This Report was released at the XVII International AIDS Conference…
Battling the Dual Epidemic through Community Action AUGUST 2008 TB/HIV: What Every HIV/AIDS Activist Should Know by Nelson Juma Otwoma I have always wanted to make a difference. My activism took root in my home province, Nyanza. My activism has…
June 4, 2008 Please find appended the response of the Treatment Action Group (TAG) to NIAID's "Request for Information (RFI): To Solicit Input and Ideas on Priorities in Basic Vaccine Discovery Research." We would also refer you to TAG's report…
Experiences & Leadership by AIDS Activists Compiled by Public Health Watch (PHW) and Treatment Action Group (TAG) 2008 Introduction The Open Society Institute’s Public Health Watch (PHW)1 and Treatment Action Group (TAG)2 began working together through a common desire to…
Treatment Action Group (TAG) today issued this statement about the discontinuation of the STEP study, an HIV vaccine efficacy trial conducted by Merck Research Laboratories and the HIV Vaccine Trials Network (HVTN).
Experimental Treatments and Preventive Therapies for HIV, Hepatitis C, and Tuberculosis: By Mark Harrington, Bob Huff, and Richard Jefferys. Reviewed by Tracy Swan, Javid Syed, Claire Wingfield, and Jen Curry.
By Tracy Swan May 31, 2007 The Henry J. Kaiser Family Foundation and the National Association of State and Territorial AIDS Directors (NASTAD) released the 2007 National ADAP Monitoring Project Annual Report on April 10th, 2007. Access to hepatitis C…
By Richard Jefferys May 2007 Anyone who follows HIV research is familiar with how a new potential therapeutic target can suddenly appear in the scientific literature, generating much excitement and hype, only to subsequently shuffle quietly from the scene having…